PubRank

Niki Karavitaki

Author PubWeight™ 28.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 2009 2.62
2 Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review. Eur J Endocrinol 2012 1.73
3 Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas. Clin Endocrinol (Oxf) 2013 1.39
4 Rathke's cleft cysts. Clin Endocrinol (Oxf) 2012 1.32
5 BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathol 2014 1.05
6 What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics. Eur J Endocrinol 2007 0.99
7 Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. J Clin Endocrinol Metab 2012 0.98
8 Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review. Eur J Endocrinol 2012 0.98
9 Opioid induced hypogonadism. BMJ 2010 0.96
10 Radiation-induced hypopituitarism. Endocr Relat Cancer 2009 0.95
11 Mini-review: pheochromocytomas causing the ectopic ACTH syndrome. Endocrine 2012 0.93
12 Nonfunctioning pituitary adenomas: the Oxford experience. Nat Rev Endocrinol 2009 0.92
13 Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. J Clin Endocrinol Metab 2012 0.89
14 Whole-exome sequencing studies of nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2013 0.89
15 Valvular heart disease and the use of cabergoline for the treatment of prolactinoma. Clin Endocrinol (Oxf) 2009 0.87
16 Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas. Eur J Endocrinol 2013 0.86
17 Clinical review: Functioning gonadotroph adenomas. J Clin Endocrinol Metab 2014 0.85
18 The management of head-and-neck paragangliomas. Endocr Relat Cancer 2013 0.82
19 Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide. Endocr Relat Cancer 2012 0.81
20 The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis. Endocr Pathol 2015 0.81
21 Confusing genes: a patient with MEN2A and Cushing's disease. Clin Endocrinol (Oxf) 2013 0.80
22 Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma? Eur J Endocrinol 2011 0.79
23 Craniopharyngiomas. Historical aspects of their management. Hormones (Athens) 2008 0.77
24 The postoperative monitoring of nonfunctioning pituitary adenomas. Nat Rev Endocrinol 2011 0.77
25 Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation? Pituitary 2008 0.77
26 The impact of chronic in vivo glucocorticoid excess on the functional characteristics of human skin fibroblasts obtained from patients with endogenous Cushing's syndrome. Eur J Endocrinol 2005 0.77
27 Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. Clin Endocrinol (Oxf) 2004 0.76
28 Hypophyseal Wegener's granulomatosis presenting by visual field constriction without hypopituitarism. Clin Neurol Neurosurg 2012 0.76
29 Clinical and biochemical manifestations of Cushing's. Pituitary 2015 0.76
30 Dandy-Walker malformation, papillary thyroid carcinoma, and SDHD-associated paraganglioma syndrome. J Clin Endocrinol Metab 2013 0.75
31 Transsphenoidal pituitary surgery in the elderly is safe and effective. Br J Neurosurg 2013 0.75
32 Treatment of pituitary tumors: history. Endocrine 2005 0.75